Health
21 Oct 2026
GSK’s Jemperli gains FDA approval for advanced rectal cancer
GSK’s immunotherapy Jemperli has received accelerated approval for locally advanced rectal cancer, offering a potential alternative to chemotherapy, radiation, and surgery.
Read more